In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species

Antimicrob Agents Chemother. 2011 Jun;55(6):3031-5. doi: 10.1128/AAC.01569-10. Epub 2011 Mar 21.

Abstract

We tested the activities of anidulafungin and other antifungal agents against clinical isolates of different fungal species. For Candida species, high sessile MIC₉₀s (SMIC₉₀s) were obtained for fluconazole, voriconazole, and amphotericin B, whereas the anidulafungin SMIC₉₀s were very low, as were those for caspofungin. Comparatively, for Aspergillus species, higher SMIC₉₀ values were obtained not only for amphotericin B and voriconazole but also for the echinocandins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anidulafungin
  • Antifungal Agents / pharmacology*
  • Aspergillus / drug effects*
  • Aspergillus / physiology
  • Biofilms / drug effects*
  • Candida / drug effects*
  • Candida / physiology
  • Caspofungin
  • Drug Resistance, Fungal
  • Echinocandins / pharmacology*
  • Lipopeptides
  • Microbial Sensitivity Tests

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Anidulafungin
  • Caspofungin